Skip to main
NHP

NHP Stock Forecast & Price Target

NHP Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

National Healthcare is a promising healthcare REIT, with a strong focus on senior housing properties that is projected to drive organic growth and increase its valuation multiple. The company is targeting a price of $18 and has plans to improve its leverage and reduce debt through asset dispositions. However, management turnover and market conditions pose potential risks and their transition to a primarily SHOP-focused portfolio may also raise sustainability concerns. The company also has a limited float and lock-up expiration for legacy investors, which may impact their stock performance in the short term.

Bears say

National Healthcare is currently facing multiple challenges, including a negative discount to FTM NAV compared to its peers in the Healthcare REIT group, the burden of complying with strict healthcare regulations and insurance in a highly regulated and challenging industry, as well as the potential risk of a pandemic outbreak which could significantly impact its senior housing and OMF tenants and rental payments. Furthermore, with a significant percentage of shares currently subject to a 180-day lockup agreement, there could be a potential for a considerable sell-off in the stock upon expiration.

NHP has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Healthcare Properties and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Healthcare Properties (NHP) Forecast

Analysts have given NHP a Buy based on their latest research and market trends.

According to 7 analysts, NHP has a Buy consensus rating as of Jun 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Healthcare Properties (NHP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.